Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (3y) (2013 - 2024)
Lexicon Pharmaceuticals (LXRX) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
174.17% |
| Sep 30, 2024 |
12.96% |
| Jun 30, 2024 |
-35.85% |
| Sep 30, 2023 |
35.99% |
| Mar 31, 2022 |
2.78% |
| Dec 31, 2021 |
-14.66% |
| Sep 30, 2021 |
314.08% |
| Jun 30, 2021 |
298.19% |
| Mar 31, 2021 |
-1.70% |
| Dec 31, 2020 |
138.11% |
| Sep 30, 2020 |
-18.52% |
| Mar 31, 2019 |
9.04% |
| Dec 31, 2018 |
-46.82% |
| Sep 30, 2018 |
-74.64% |
| Jun 30, 2018 |
-68.12% |
| Mar 31, 2018 |
33.01% |
| Dec 31, 2017 |
-51.00% |
| Sep 30, 2017 |
105.78% |
| Jun 30, 2017 |
86.19% |
| Mar 31, 2017 |
48.67% |
